Cargando…
The oncogenic E3 ligase TRIP12 suppresses epithelial–mesenchymal transition (EMT) and mesenchymal traits through ZEB1/2
Thyroid hormone receptor interactor 12 (TRIP12) is an E3 ligase most notably involved in the proteolytic degradation of the tumor suppressor p14ARF. Through this process, it is proposed that TRIP12 plays an oncogenic role in tumor initiation and growth. However, its role in other cancer processes is...
Autores principales: | Lee, Kwok Kin, Rajagopalan, Deepa, Bhatia, Shreshtha Sailesh, Tirado-Magallanes, Roberto, Chng, Wee Joo, Jha, Sudhakar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8105346/ https://www.ncbi.nlm.nih.gov/pubmed/33963176 http://dx.doi.org/10.1038/s41420-021-00479-z |
Ejemplares similares
-
TIP60 represses activation of endogenous retroviral elements
por: Rajagopalan, Deepa, et al.
Publicado: (2018) -
GRHL2 Acts as an Anti-Oncogene in Bladder Cancer by Regulating ZEB1 in Epithelial-Mesenchymal Transition (EMT) Process
por: Shen, Jingang, et al.
Publicado: (2020) -
GRHL2 Acts as an Anti-Oncogene in Bladder Cancer by Regulating ZEB1 in Epithelial-Mesenchymal Transition (EMT) Process [Erratum]
Publicado: (2020) -
Oncogenic functions of the EMT-related transcription factor ZEB1 in breast cancer
por: Wu, Hua-Tao, et al.
Publicado: (2020) -
TIP60 represses telomerase expression by inhibiting Sp1 binding to the TERT promoter
por: Rajagopalan, Deepa, et al.
Publicado: (2017)